The lab studies the interaction of drugs with hERG, in part because the off-site inhibition of hERG by drugs can cause an acquired form of Long QT. The FDA issued a guidance for industry due to these concerns.

It is important to be aware that new drugs, or re-purposing drugs to treat new diseases, including covid-19, have the potential for serious cardiac side effects. The FDA has issued guidance for the use of hydroxychloroquine and choroloquine for covid-19.